Talitha Bakker
Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland
In presentations
Saturday, June 27, 04:00 PM – 04:00 PM
Daridorexant in patients with insomnia disorder: number needed to treat, number needed to harm & likelihood to be helped or harmed
Speaker: Talitha Bakker (Idorsia Pharmaceuticals Ltd, Global Medical Affairs, Allschwil, Switzerland)
Saturday, June 27, 04:00 PM – 04:00 PM
Effect of daridorexant on wakefulness throughout the night: post-hoc analysis of a randomised, double-blind, active reference (zolpidem) study in patients with insomnia disorder
Speaker: Talitha Bakker (Idorsia Pharmaceuticals Ltd, Global Medical Affairs, Allschwil, Switzerland)